Merck Sues Cobalt Over ANDA For Generic Fosamax
Drug maker Merck & Co. has sued Canada's Cobalt Pharmaceuticals over its plans to make a generic version of its best-selling osteoporosis treatment Fosamax....To view the full article, register now.
Already a subscriber? Click here to view full article